IRIS
CARAMORI, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.931
NA - Nord America 4.452
SA - Sud America 2.106
EU - Europa 1.638
AF - Africa 580
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.731
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.522
US - Stati Uniti d'America 4.203
BR - Brasile 1.556
VN - Vietnam 1.413
HK - Hong Kong 983
CN - Cina 886
ZA - Sudafrica 413
NL - Olanda 383
FR - Francia 358
IT - Italia 288
AR - Argentina 213
IN - India 199
RU - Federazione Russa 194
BD - Bangladesh 182
DE - Germania 103
MX - Messico 97
IQ - Iraq 91
CA - Canada 87
EC - Ecuador 87
GB - Regno Unito 80
TR - Turchia 76
CO - Colombia 70
PK - Pakistan 69
ID - Indonesia 66
VE - Venezuela 55
JP - Giappone 51
UZ - Uzbekistan 47
CL - Cile 45
PH - Filippine 43
PL - Polonia 38
MA - Marocco 36
SA - Arabia Saudita 36
MY - Malesia 34
TN - Tunisia 33
AT - Austria 29
PY - Paraguay 29
KR - Corea 24
PE - Perù 24
UA - Ucraina 22
ES - Italia 21
KE - Kenya 20
TH - Thailandia 20
EG - Egitto 19
JO - Giordania 19
SE - Svezia 19
AE - Emirati Arabi Uniti 18
AU - Australia 16
NP - Nepal 15
BO - Bolivia 14
FI - Finlandia 14
IR - Iran 14
UY - Uruguay 13
AL - Albania 12
LB - Libano 12
TW - Taiwan 12
KZ - Kazakistan 11
AZ - Azerbaigian 10
IL - Israele 10
OM - Oman 10
DO - Repubblica Dominicana 9
GT - Guatemala 9
IE - Irlanda 9
CI - Costa d'Avorio 8
ET - Etiopia 8
KG - Kirghizistan 8
PS - Palestinian Territory 8
SN - Senegal 8
BG - Bulgaria 7
CR - Costa Rica 7
HN - Honduras 7
LT - Lituania 7
NI - Nicaragua 7
PA - Panama 7
RO - Romania 7
BY - Bielorussia 6
CY - Cipro 6
DZ - Algeria 6
AM - Armenia 5
BH - Bahrain 5
GE - Georgia 5
HU - Ungheria 5
JM - Giamaica 5
PT - Portogallo 5
QA - Qatar 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AO - Angola 4
GR - Grecia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
CG - Congo 3
HR - Croazia 3
MK - Macedonia 3
MN - Mongolia 3
MU - Mauritius 3
NG - Nigeria 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BF - Burkina Faso 2
CZ - Repubblica Ceca 2
Totale 17.686
Salva come PNG Salva come JPEG
Città #
Singapore 1.770
San Jose 1.384
Hong Kong 953
Ho Chi Minh City 492
Santa Clara 404
Johannesburg 383
Boardman 361
Ashburn 345
Lauterbourg 319
Hanoi 302
Dallas 295
Los Angeles 200
Moscow 133
São Paulo 131
Beijing 129
New York 79
Buffalo 72
Columbus 60
Da Nang 60
Rio de Janeiro 56
Milan 55
Haiphong 44
Shanghai 44
Tashkent 44
Hefei 42
Tokyo 40
Brooklyn 38
Munich 37
Baghdad 35
Warsaw 35
Belo Horizonte 34
Hải Dương 33
Biên Hòa 32
Mexico City 32
Montreal 31
Nuremberg 31
Parma 31
Medellín 30
Quito 29
Toronto 29
Chennai 28
Brasília 26
Frankfurt am Main 26
Guayaquil 25
Orem 25
Dhaka 24
Council Bluffs 23
Caracas 22
Guarulhos 22
San Francisco 22
Porto Alegre 21
Curitiba 20
Lahore 20
Fortaleza 19
Mumbai 19
Santiago 19
Amman 18
Thái Bình 18
Bắc Ninh 17
Chicago 17
Kuala Lumpur 17
Lima 17
Phoenix 17
Assago 16
Can Tho 16
Nairobi 16
Denver 15
Guangzhou 15
Karachi 15
London 15
Ribeirão Preto 15
Riyadh 15
Campinas 14
Naples 14
Rome 14
Secaucus 14
Tianjin 14
Atlanta 13
Buenos Aires 13
Rio Claro 13
Stockholm 13
Bắc Giang 12
Jakarta 12
Jeddah 12
Montevideo 12
Quảng Ngãi 12
Sydney 12
The Dalles 12
Thái Nguyên 12
Istanbul 11
Manaus 11
Nha Trang 11
Sorocaba 11
Ankara 10
Asunción 10
Boston 10
Cape Town 10
Changsha 10
Huế 10
Karbala 10
Totale 9.606
Salva come PNG Salva come JPEG
Nome #
Onset of ANCA-positive EGPA with bilateral pleural effusion: a case report 136
Breathing pattern and ventilatory response to exercise in patients with Chronic Obstructive Pulmonary Disease 112
Methotrexate in the treatment of systemic glucocorticoid dependent severe persistent astma: a word of caution 105
Adverse roles of mast cell chymase-1 in COPD 100
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease 98
A rare case of sudden blindness following mepolizumab withdrawal in EGPA 96
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 95
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive 94
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 92
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future 88
Airway obstruction in chronic obstructive pulmonary disease 83
Poxviridae Pneumonia 80
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 79
A case of fibrosing interstitial pneumonia 78
Differential expression of RNA-binding proteins in airway epithelium in chronic lung inflammation 77
Activation of NF-kappaB transcription factor in asthma death 76
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 74
Allergen Responses Modified by a GATA3 DNAzyme 73
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 73
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression 73
Pathology of Asthma 72
Broncodilatatori nella terapia delle broncopneumopatie croniche ostruttive 70
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 69
Posttranscriptional regulation of airway epithelial responses by the RNA binding protein AUF-1 69
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 69
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology 69
Glucocorticoidi per via inalatoria nel trattamento della patologia polmonare dell’adulto 69
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 68
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 67
Decreased T-lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease 67
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio 67
A link between lung injury and inflammatory myopathies: making the diagnosis 66
Transcription factors in asthma and COPD 66
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 65
Alterations of humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease 65
Anatomia e fisiologia clinica della pleura 65
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase 65
Marcatori infiammatori nella diagnosi e nel monitoraggio dell’ asma 64
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 64
La teofillina nella BPCO: nuove prospettive (3° parte) 64
Implementazione delle linee guida sull’asma bronchiale in Italia: l’opinione del medico di medicina generale 64
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 64
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 63
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation 63
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 63
Physiologic consequences of long-term inflammation 63
Immunomodulatory effect of gefitinib in epidermal growth factor receptor tyrosine kinase inhibitors sensitive and resistant Non small cell lung cancer: role of the RNA binding protein HuR 62
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview 62
Expression of heme-oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: effects of inhaled corticosteroids 62
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 62
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 62
Mechanisms of respiratory virus-induced asthma exacerbations 62
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 62
Ruolo dei marcatori non invasivi di stress ossidativo nelle broncopneumopatie croniche ostruttive 62
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto 62
FN3K expression in COPD: A potential comorbidity factor for cardiovascular disease 62
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 61
Ruolo delle chinine nella patologia polmonare dell'adulto 61
Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease 61
Sex differences and disparities in cardiovascular outcomes of COVID-19 61
Delivery systems e protocollo di Montreal 61
Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study 61
Transcription Factors 61
Pathogenic link between chronic obstructive pulmonary disease and squamous cell lung cancer 61
Clinical definition of COPD exacerbations and classification of their severity 60
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO) 60
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease (vol 7, e000714, 2020) 60
IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection 59
Nuove linee guida internazionali per la terapia farmacologica dell’asma 59
Stem Cells/Lung Organoids and Lung Rejuvenation in the Treatment of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 59
Basi fisiopatologiche per la diagnosi delle malattie della pleura nell’adulto. Parte 1 59
Oxidants and asthma 58
Auto-antibodies against carbonyl-modified vimentin in COPD: potential role as a biomarker 58
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia 58
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease 58
Molecular mechanisms of respiratory virus-induced inflammation 58
Controllo dell’asma e delle BPCO nella medicina Generale 57
Sintesi delle nuove linee guida internazionali per la terapia farmacologica dell’asma 57
Molecular links between COPD and lung cancer: new targets for drug discovery? 57
Pathophysiology of viral-induced exacerbations of COPD 57
Nuove strategie terapeutiche delle broncopneumopatie croniche ostruttive 56
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 56
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease 56
Pulmonary vasculitis: classification, clinical features and management 56
Quality of life in asthma and COPD: is it measurable in primary care? 56
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 55
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 55
Sport e inquinamento atmosferico 55
Definizione e basi biologiche della broncopneumopatia cronica ostruttiva 55
Stato dell’arte degli antileucotrienici nella terapia dell’asma 55
Trattamento del pneumotorace 55
Evaluation by self-monitoring and noninvasive measures 54
Regulation of Wnt4 in chronic obstructive pulmonary disease 54
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 54
New targets for drug development in asthma 54
Effect of acute and chronic inflammatory stimuli on expression of protease-activated receptors 1 and 2 in alveolar macrophages 54
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease 54
Degree of control of physician-diagnosed asthma and COPD in Italy 54
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare 54
Classificazione e metodi di indagine del pneumotorace 54
Totale 6.640
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.228
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024943 0 0 0 0 343 30 43 6 21 97 103 300
2024/20255.140 21 401 373 28 525 400 120 120 945 684 341 1.182
2025/202612.014 865 1.474 1.862 1.144 1.633 374 2.006 374 1.500 782 0 0
Totale 18.097